Skip to Content

Plandai Biotechnology Inc PLPL

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Plandai Biotechnology Inc is a US-based biopharmaceutical company. It focuses on the production of proprietary botanical extracts for the nutraceutical and pharmaceutical industries. The company grows the green tea used in its Phytofare Catechin production. Plandaí uses a proprietary extraction process that is engineered to yield bioavailable products of pharmaceutical-grade purity. The products of the company include Phytofare Catechin Complex, a green-tea derived extract, is a commercial product in the Phytofare brand and has clinical data supporting its use in multiple potential wellness applications.

17 Hanover Square
London, W1S 1BN, United Kingdom
T +44 4358813611
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Mar 31, 2017
Fiscal Year End Jun 30, 2017
Stock Type Distressed
Employees 100